- $22.63bn
- $24.06bn
- $5.94bn
Steris rises after second-quarter results beat
Steris Q2 adjusted EPS beats; fiscal 2027 outlook lifted
Brief: Steris Q2 Adjusted EPS USD 2.94 Vs. IBES Estimate USD 2.68
Cooper Companies CEO White steps down (updated)
Brief: CooperCompanies Announces Leadership Transition And Board Refreshment
Cooper Companies CEO White steps down; board member Rosebrough named executive chair
Press Digest: Wall Street Journal - October 13
Steris gains on $2.1 bln Xodus Medical buy
Deals of the day-Mergers and acquisitions
Brief: STERIS Expands Healthcare Consumables Offering With Definitive Agreement To Acquire Xodus Medical, A Specialty Surgical Products Business Focused On Patient And OR Staff Safety
Steris doubles down on healthcare consumables with $2.1 billion Xodus buy (updated)
Steris buys surgical products maker Xodus Medical for $2.1 billion
Steris Plc Reports Results For The Quarter Ended June 30: Earnings Summary
Steris Q1 adjusted EPS beats estimates, revenue up 7%
Brief: Steris Q1 Adjusted EPS USD 2.59 Vs. IBES Estimate USD 2.5
Steris to invest $600 million in new North Carolina chemicals manufacturing hub
Steris Plc Expected To Post Earnings Of $2.50 A Share: Earnings Preview
Steris forecasts 2027 profit above estimates, banks on procedure-driven demand
Steris misses Q4 adjusted profit expectations; sets $1 bln buyback